Ranomed
(Ranolazine Extended Release Tablets 500 mg)
Chronic Angina Relief
Maintains BP/HR
Cellular Action
Ranomed 500 contains Ranolazine 500 mg, an extended-release formulation used in the management of chronic stable angina. It works at the cellular level by improving blood flow to help the heart work more efficiently. Unlike beta-blockers or nitrates, Ranolazine does not reduce blood pressure or heart rate, making it suitable for patients who can’t tolerate other anti-anginal medications.
Uses:
- Long-term management of chronic stable angina pectoris
- Adjunctive therapy with beta-blockers, nitrates, calcium channel blockers, or ACE inhibitors
Key Benefits:
- Helps relieve chronic stable angina
- Improves exercise capacity and reduces chest pain episodes
- Can be used alongside other anti-anginal drugs
- Maintains stable hemodynamics — safe for patients with bradycardia or low BP
How It Works
Ranolazine works by inhibiting the late phase of the inward sodium current in cardiac cells. This reduces intracellular calcium overload, decreases myocardial wall tension, and improves oxygen efficiency, especially during stress. This action leads to better control of angina symptoms without negatively impacting heart rate or blood pressure.
Common Side Effects
- Dizziness
- Constipation
- Nausea
- Headache
- Fatigue
Safety Warnings
- Pregnancy: Use only if clearly needed and prescribed; not recommended without physician guidance.
- Lactation: Avoid during breastfeeding unless directed by a healthcare provider.
- Children: Not recommended under 18 years of age.
- Kidney/Liver Impairment: Caution advised; dosage adjustment may be necessary.
- Drug Interactions: Avoid strong CYP3A inhibitors or inducers (consult your doctor).
- Driving/Operating Machinery: May cause dizziness — avoid such tasks.
Important Note
Ranomed 500 should only be used under medical supervision. It is not intended for acute angina attacks. Always follow your doctor’s dosage instructions carefully. Do not discontinue suddenly without consultation. Ensure regular follow-ups and disclose all concurrent medications to avoid interactions.